HALO Precision Diagnostics

08/16/2023

Welcome John Craighead, our newly appointed COO and CFO, to the HALO Precision Diagnostics team.

“John’s deep life science industry experience and business and financial acumen will serve HALO well as we pursue our life-saving mission. Together we will make personalized medicine more accessible and affordable, transforming how patients and their doctors get ahead and stay ahead of deadly diseases.” - Michael Uhl, HALO CEO

HALO Precision Diagnostics (“HALO”), the leader in early disease detection using precision diagnostics, today announced the appointment of John Craigh

05/26/2023

We are thrilled to announce the launch of our brand-new CT service line at the HALO MRI Center and HALO Breast Care Center in Chico, CA!

As a leading healthcare provider, we are proud to continue enhancing and improving our services to provide top-quality patient care. The introduction of our state-of-the-art CT technology will help provide the highest quality of diagnostic imaging services to residents of the greater Chico area.

Contact us today to schedule your CT appointment or to learn more about our comprehensive CT services: https://www.halodx.com/locations/chico-ca/

04/28/2023

Transurethral ultrasound ablation, also known as TULSA-Pro, is a minimally invasive prostate cancer procedure that allows doctors to customize treatment for each patient.

TULSA-Pro has several advantages over other treatment procedures, including being a minimally invasive outpatient procedure, a decreased risk of side effects, and the option to repeat treatment or choose any other treatment if your prostate cancer returns.

Learn more about this quality of life-preserving prostate cancer treatment, offered through HALO’s Comprehensive Men’s Health program: https://www.halodx.com/sarasota-mens-health/

04/26/2023

Over the past 20 years Dr. Stephen Scionti, Prostate Cancer Program Director for HALO Precision Diagnostics, has developed the largest and most experienced practice for prostate cancer treatment using minimally invasive thermal ablation technologies such as HIFU, TULSA-Pro, Cryoablation and Prostate Laser Ablation.

Dr. Scionti is the most experienced HIFU physician in the United States, with over 17 years of HIFU experience and 2000 procedures.

Additionally, Dr. Scionti’s practice, the Scionti Prostate Center, was the first TULSA Procedure site in North America, post-FDA approval.

Learn more about our Comprehensive Men’s Health program and the cutting-edge technology that is saving men’s lives with less lifestyle compromise: https://www.halodx.com/sarasota-mens-health/

04/24/2023

Broader than Focal, Less than Total: the TULSA Procedure is a customizable, predictable, and incision-free treatment for prostate cancer.

TULSA-Pro can cover almost the entire prostate gland in patients with a relatively larger cancer or somewhat diffuse cancer within the prostate. Additionally, this treatment option offers a decreased risk of urinary incontinence and erectile dysfunction.

The Scionti Prostate Center, now part of HALO’s Comprehensive Men’s Health program, was the first TULSA Procedure site in North America, post-FDA approval, and has performed over 200 procedures.

If you are seeking quality of life-preserving prostate cancer treatment, look no further than the experienced professionals at Scionti Prostate Center: https://www.halodx.com/sarasota-mens-health/

04/21/2023

Dr. Stephen Scionti is an internationally recognized authority in innovative prostate cancer diagnostics. He is the Founder and Director of his practice, the Scionti Prostate Center in Sarasota, Florida, now part of HALO’s Comprehensive Men’s Health program.

Over the past 20 years, Dr. Scionti has developed the largest and most experienced practice for prostate cancer treatment using minimally invasive thermal ablation technologies such as HIFU, TULSA-Pro, Cryoablation and Prostate Laser Ablation. He has achieved global recognition for his experience, skill and groundbreaking clinical contributions in the field of image-guided prostate cancer ablation.

Dr. Scionti furthers his expertise through active research and lectures on the outcomes and technology associated with minimally invasive prostate HIFU therapy ablation.

To learn more about Dr. Scionti and book an appointment, visit our website: https://www.halodx.com/sarasota-mens-health/team/

04/20/2023

HALO Precision Diagnostics is committed to early-stage disease screening, diagnosis, and care through the latest medical advances available. We are expanding our network to Northern Florida with the addition of our Sarasota prostate screening, diagnosis and therapeutics center.

We’ve joined forces with Dr Stephen Scionti, Founder and Director of the Scionti Prostate Center, who has global recognition for his 20+ years of experience, skill and groundbreaking clinical contributions in the field of image-guided prostate cancer ablation.

To learn more about how HALO is providing superior services in the line of men’s health, visit our website: https://www.halodx.com/sarasota-mens-health/

04/07/2023

HALO is hiring!

HALO Precision Diagnostics has set out to do something exceptional by setting a new personalized standard of healthcare with precision diagnostics. We are helping people detect deadly diseases earlier; This allows for less-invasive, more-precise treatment sooner and a longer, better quality of life.

We are always looking to add driven and compassionate employees to our team who are motivated by our mission to save lives with precision diagnostics. Watch our latest YouTube video and see if the HALO team is a good fit for you: https://youtu.be/sPxt3xKpbd4

HALO is the leader in early disease detection using precision diagnostics. We are actively hiring in all locations. To view all open positions and submit you...

04/03/2023

HALO Precision Diagnostics is bringing the latest in advanced imaging technology to our Indian Wells, CA location with our new Philips 128-slice CT 5100 Incisive that utilizes deep-learning AI.

This revolutionary machine features AI technology that enhances the precision, speed, and image quality of our CT scans, ensuring faster, more comfortable, and more accurate scans for our patients.

Learn more about how HALO is providing a superior patient experience in medical imaging: http://ow.ly/rrYQ50NyZ6O

We are bringing the latest in advanced imaging technology to the Coachella Valley with our new CT 5100 Incisive that utilizes deep-learning AI.

03/31/2023

HALO is the leader in early detection of cancer using precision diagnostics.

Dr. John Feller, Chief Medical Officer for HALO Precision Diagnostics, recently shared his background and personal expertise on cancer with Authority Magazine for their interview series “5 Things Everyone Needs to Know About Cancer”.

Check out Dr. Feller’s 5 pieces of advice about cancer in our recent blog: http://ow.ly/rqyP50NxI53

Dr. John Feller, Chief Medical Officer for HALO, shares “The 5 Things Everyone Needs to Know About Cancer” with Authority Magazine.

03/28/2023

HALO Precision Diagnostics is proud to receive the ACR’s Breast Imaging Center of Excellence designation at our HALO MRI Center and HALO Breast Care Center.

We’ve met the American College of Radiology's highest standards for quality and safety in medical imaging, giving our patients confidence and peace of mind when choosing us for all their breast screening needs.

The Center of Excellence designation recognizes facilities that are ACR-accredited in mammography, stereotactic breast biopsy, and breast ultrasound (including ultrasound-guided breast biopsy).

Learn more about how we are continuing to deliver world-class care to our patients: http://ow.ly/FBuX50Nu3Ph

HALO Breast Care Center is now an ACR-accredited BICOE, providing the highest standards of quality and safety in breast screening.

03/16/2023

HALO is passionate about early disease detection and strongly supports recent California Bill AB 632, passed earlier this month.

Bill AB 632 will allow patients to receive prostate cancer screenings without a deductible, copayment, or coinsurance, and is tailored to apply to men over the age of 55 and men over the age of 40 who are at high risk.

Read our recent blog to learn more about the impact of prostate cancer and why early detection is vital: http://ow.ly/rIMZ50NkpJg

CA Bill 632 will allow more men to receive prostate cancer screenings without the worry of healthcare expenses.

03/14/2023

HALO Precision Diagnostics™ is a leader in early disease detection using precision diagnostics and a proud partner of the Prostate Cancer Foundation.

In alignment with their Black History Month Assist Challenge with the Atlanta Hawks, the PCF teamed up with Black celebrities to help emphasize the importance of early detection of prostate cancer in Black men for their campaign “Black Men: Know Your Risk”.

Prostate cancer is a highly treatable disease when detected early. 1-in-6 Black men will develop prostate cancer in their lifetimes, making early detection vital.

Read more about the PCF’s powerful campaign: http://ow.ly/ll9h50NibZF

The PCF's recent campaign highlights the disproportionate prostate cancer burden on Black men and the importance of early detection.

03/08/2023

Urologists choose the HALO PathWay™ for prostate cancer because we are the leader in early disease detection using precision diagnostics. Personalized healthcare has gotten very complex, but for the first time, the most-advanced imaging, screenings, genetic tests, and therapies are integrated under one roof, in a lower-cost, outpatient setting – improving the patient experience and saving lives.

The all-new HALO Experience provides all the testing for your patients’ needs. Our genetic test ensemble equips patients and providers with the most advanced imaging, biomarker testing, genetic testing, and predictive analysis of a patient’s risk of prostate cancer and helps to guide those at high risk through additional screening and treatment, if necessary. The result is a one-stop patient and referring physician experience that has the potential to save lives with precision diagnostics.

99% of high-grade cancers are detected when the mpMRI, PSA Density, and urine biomarkers are used together. By combining imaging, lab, and genetic test results, HALO can detect signs of prostate cancer with more confidence. If a high-likelihood is found, the PrecisionDx Report will provide recommendations for next steps. When all three of these tests are combined, we miss 1% or less of clinically significant prostate cancers, helping to decrease the blind spots of each these tests and prevent over-treatment.

When detected early, the 5-year survival rate for men diagnosed with prostate cancer is greater than 99%. Cancer that is diagnosed earlier requires less invasive surgery and treatment for improved outcomes. Prostate cancer is highly treatable, and with the appropriate education around the steps towards early detection with precision diagnostics, most men can continue to lead active, healthy lives many years after diagnosis.

View our latest video on YouTube to learn more: http://ow.ly/Ej8u50NcgnN

HALO Diagnostics™ is the leader in early disease detection using precision diagnostics. Personalized healthcare has gotten very complex, but for the first ti...

03/02/2023

A comprehensive 2017 study published by the American Cancer Society looked at a broad range of lifestyle factors and 26 different cancer types in adults ages 30 years and older to uncover how cancer deaths could be attributed to modifiable risk factors.

While several factors can contribute to your risk of cancer, making healthy lifestyle choices and getting regular screenings can help you lower your risk and catch cancer in its earliest and most treatable stages.

Discover what lifestyle habits can increase your risk of these different cancers: http://ow.ly/UQLN50N7ySW

There are several lifestyle factors that can put you at an increased risk of developing cancer. Check out what they are and how to avoid them.

02/23/2023

HALO Precision Diagnostics™ is proud to offer the HALO Pathway for Breast Cancer at our ACR-accredited HALO Breast Care Center in Chico, CA.

For the first time in an outpatient setting, patients can receive personalized medicine through the HALO Way that includes the most-advanced imaging, population-based analytics, and genetic testing, all performed under one roof.

Read more on the ways HALO is saving lives through early detection at our Northern California imaging center: https://www.halodx.com/blog/halo-breast-care-center-launches-new-halo-pathway-for-early-detection-of-breast-cancer/

HALO Breast Care Center now offering the HALO PathWay™ for breast - an improved breast cancer screening approach.

02/21/2023

HALO Precision Diagnostics™ is the leader in early disease detection using precision diagnostics. Our newly launched HALO Way features our genetic testing one-stop-shop experience for the early detection of the deadliest diseases: cardiac, neuro, and cancer.

While gene mutations are not common, having one means it was likely passed down from one or both of your parents. In some cases, a specific gene mutation can be the cause of several different types of cancer.

A gene mutation does not guarantee you will develop cancer, but it increases your risk. If you have a gene mutation or are curious about genetic testing, read more in our blog: http://ow.ly/Xqi150MYhL2

Knowing that you have a genetic mutation can give you an advantage when it comes to taking a proactive approach to your health. Learn why!